No Data
No Data
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating, Announces Target Price $10
Barrington Remains a Hold on Lifecore Biomedical (LFCR)
Lifecore Biomedical Hosts Virtual Investor Day
Lifecore Biomedical Plans Strategic Growth and Transformation
US Manufacturing Index Rises To 43, Highest Since 2020
Here's Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)
No Data
No Data